Literature DB >> 21111964

Immunotherapy of melanoma: an update.

Jade Homsi1, Joshua C Grimm, Patrick Hwu.   

Abstract

The incidence of melanoma has been increasing worldwide. A relationship between melanoma and the immune system was established years ago. Modulating the immune system in the management of different stages of melanoma has been the focus of numerous large randomized trials worldwide. This article reviews the current status of immunotherapy for melanoma, with a focus on the recent promising results from using vaccines, cytotoxic T-lymphocyte antigen-4 (CTLA-4) antibodies, and adoptive cell therapy.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21111964     DOI： 10.1016/j.soc.2010.09.004

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  3 in total

1.  Identification of an HLA-DPB1*0501 restricted Melan-A/MART-1 epitope recognized by CD4+ T lymphocytes: prevalence for immunotherapy in Asian populations.

Authors:  Zhaoting Meng; Yadong Wang; Guanzhong Zhang; Yuehua Ke; Yanfeng Yan; Liangliang Wu; Qianrong Huang; Gang Zeng; Yu Wang; Han Ying; Shunchang Jiao
Journal:  J Immunother       Date:  2011-09       Impact factor: 4.456

2.  Antitumor T-cell responses contribute to the effects of dasatinib on c-KIT mutant murine mastocytoma and are potentiated by anti-OX40.

Authors:  Yan Yang; Chengwen Liu; Weiyi Peng; Gregory Lizée; Willem W Overwijk; Yang Liu; Scott E Woodman; Patrick Hwu
Journal:  Blood       Date:  2012-08-30       Impact factor: 22.113

3.  A Phase I trial using local regional treatment, nonlethal irradiation, intratumoral and systemic polyinosinic-polycytidylic acid polylysine carboxymethylcellulose to treat liver cancer: in search of the abscopal effect.

Authors:  Andrew N de la Torre; Sohail Contractor; Ismael Castaneda; Charles S Cathcart; Dolly Razdan; David Klyde; Piotr Kisza; Sharon F Gonzales; Andres M Salazar
Journal:  J Hepatocell Carcinoma       Date:  2017-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.